Vitrafy Life Sciences Ltd (VFY)

Currency in AUD
1.60
0.00(0.00%)
Closed·
VFY Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
VFY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.601.60
52 wk Range
1.082.10
Key Statistics
Bid/Ask
1.36 / 1.60
Prev. Close
1.6
Open
1.6
Day's Range
1.6-1.6
52 wk Range
1.08-2.1
Volume
309
Average Volume (3m)
21.71K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VFY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.11
Upside
+31.61%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Vitrafy Life Sciences Ltd Company Profile

Vitrafy Life Sciences Limited provides cryopreservation solutions in Australia. Its cryopreservation technology improves the cell survival of cryopreserved biological materials, such as blood platelets used to treat trauma patients, t cells used in cancer treatments, and animal sperm used in breeding and farming. The company provides smart freezing device, smart thawing device, and LifeChain, a sample quality management software platform, as well as smart blood bag and sperm packaging solution. It serves animal genetics and animal reproduction suppliers; blood platelets organizations, biobanks, and points of care; and human cell and gene therapies markets. The company has research and collaboration agreement with CSL Innovation Pty Ltd, US Army Institute of Surgical Research, Select Sires, Inc. and a Huon Aquaculture Company Pty Ltd. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.

Compare VFY to Peers and Sector

Metrics to compare
VFY
Peers
Sector
Relationship
P/E Ratio
−3.1x−0.9x−0.5x
PEG Ratio
−0.040.000.00
Price/Book
3.6x1.4x2.6x
Price / LTM Sales
97.5x3.6x3.3x
Upside (Analyst Target)
31.7%114.1%43.5%
Fair Value Upside
Unlock14.2%6.9%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2.11
(+31.61% Upside)

Earnings

Latest Release
Aug 04, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
155.12K / --
EPS Revisions
Last 90 days

VFY Income Statement

FAQ

What Stock Exchange Does Vitrafy Life Sciences Trade On?

Vitrafy Life Sciences is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Vitrafy Life Sciences?

The stock symbol for Vitrafy Life Sciences is "VFY."

What Is the Vitrafy Life Sciences Market Cap?

As of today, Vitrafy Life Sciences market cap is 102.16M.

What Is Vitrafy Life Sciences's Earnings Per Share (TTM)?

The Vitrafy Life Sciences EPS (TTM) is -0.73.

From a Technical Analysis Perspective, Is VFY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Vitrafy Life Sciences Stock Split?

Vitrafy Life Sciences has split 0 times.

How Many Employees Does Vitrafy Life Sciences Have?

Vitrafy Life Sciences has 22 employees.

What is the current trading status of Vitrafy Life Sciences (VFY)?

As of 07 Aug 2025, Vitrafy Life Sciences (VFY) is trading at a price of 1.60, with a previous close of 1.60. The stock has fluctuated within a day range of 1.60 to 1.60, while its 52-week range spans from 1.08 to 2.10.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.